CFD Research awarded DTRA chemical warfare agent research contract
CFD Research has received an award from the Defense Threat Reduction Agency to explore mechanisms, countermeasures and interventions for chemical warfare exposure. Chemical Warfare agents cause catastrophic medical disasters and have the ability to overwhelm any healthcare system. Extremely toxic, inexpensive and relatively easy to produce, these agents induce common cellular, molecular and inflammatory pathways resulting in acute inflammation, toxicity, and ultimately organ failure. CFD Research has a two-fold goal two-fold goal of identifying interventions nodes among the common inflammatory pathways while furthering identification of FDA approved drugs against these nodes. Known drugs will also be checked for their possibility in being a therapeutic target.
